MONROVIA, CA, October 08, 2009
/24-7PressRelease/ -- GTCbio is proud to present its 7th Annual Vaccines: "All Things Considered" conference to be held this year in Washington, D.C. on Nov 9-10, 2009. This conference promises to be the one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy.
The research and discovery of vaccines to fight globally prevalent diseases has been a major focus of the pharmaceutical industry's biggest players for decades. The pharmaceutical world has been rocked recently by the pending expiration of patents on several major block-buster drugs. How does this affect funding for vaccine research and development? What will be the path forward? How will the generic drug industry affect the vaccines market? These are just a few of the questions the Vaccines conference will address and answer.
Recent advancements in the discovery of novel vaccines that target not only traditional infectious diseases (such as Malaria, Influenza, AIDS, Meningitis, etc), but non-infectious diseases such as cancer, allergies, and even smoking, prove to be both innovative and promising for the industry. The Vaccines conference is the perfect forum to network with colleagues and gain valuable information on these exciting next generation vaccines.
In the spirit of truly considering all things, GTCbio's Vaccines conference will also bring together leading government officials, with representatives from the DHHS and the FDA, to provide a first-hand perspective into current US vaccines policy and regulation. Updates on the pandemic and bio-defense policy as well as the National Vaccine Plan will be addressed and discussed.
Gaining a proficient understanding of and accounting for the aforementioned factors in vital before moving forward with Vaccine discovery and development. Don't miss an opportunity to take all things into consideration and register for GTCbio's 7th Annual Vaccines: "All Things Considered" conference.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
- adjuvants, avian, conferences, cutaneous, delivery, drug, flu, gtcbio, immunization, influenza, maternal, meningococcus, methods, platforms, rotavirus, toxicology, tuberculosis, vaccination, vaccines, varicella-zoster
Read more Press Releases from Rania Hafez:- Joost Oppenheim, M.D., Laboratory Chief - NCI, to give Keynote Presentation at GTCbio's 8th Cytokines & Inflammation Conference on January 28-29, 2010 in San Diego, CA
- Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference to be held on October 14-16, 2009 in San Diego, CA
- Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
- Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio on October 14-16, 2009 in San Diego, CA.
- GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009.
- Dr. Joseph Bolen, CSO of Millennium to give Keynote Presentation at GTCbio's 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, MA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
- Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio's Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
- Alison Goss Eng of US Dept. of Energy to Present at GTCbio's Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 29-30, 2009 in San Francisco, CA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
Other Press Release Headlines:
